SJTRI is a private, non-profit preclinical research institute that combines the efficiencies of a commercial contract research organization (CRO) with the resources of an academic institution. With more than a decade of experience, SJTRI understands how to catalyze clinical solutions faster with the highest quality and the best value. STJRI offers their domestic and international partners: preclinical resources; capabilities to test, develop, and differentiate medical products; collaborative funding opportunities, including government SBIRs and STTRs; co-development of medical devices; physician education and training; and, access to clinical resources.

MetricIreland is a new research and innovation consortium for the medical technology sector, involving 5 founding Higher Education Institutes in Ireland – Athlone Institute of Technology (AIT), Galway Mayo Institute of Technology (GMIT), Institute of Technology, Sligo (ITS), National University of Ireland, Galway (NUI Galway) and University of Limerick (UL). There are also 2 associate partners – BMW Regional Assembly and Georgia Tech Ireland (GTI). Its objective is to provide support and innovation to the medical technology sector through research and development, equipment utilisation and education/training. Metricireland’s mission is to provide rapid and effective access to the capacity and capabilities within the consortium, the associate members and the broader HEI sector for enterprises.

The Atlanta Pediatric Device Consortium is an FDA funded consortium that provides a national platform to translate ideas through its product development pathway all the way to commercialization. The mission of the APDC is to enhance the lives of children through the development of novel pediatric medical devices, which are both safe and effective. The Consortium will develop an environment of creativity, with an expectation that ideas will be reviewed, tested and developed.

The APDC provides support for commercialization of devices for pediatric healthcare from initial concept to the completed marketed product. The Consortium brings together exisiting centers of excellence in the Atlanta region to provide a seamless, cost effecient development pathway that cna be accessed from academia or the private sector.

The I3L is being designed to move the health information technology (HIT) industry to the “future state” required to facilitate patient-centered, economically feasible, improved quality healthcare for the benefit of personal and public health. As a mainly virtual lab, it is an Internet Gateway to resources within other data centers on the internet collectively known as the Georgia Tech I3L Health Cloud. In addition to resources hosted at Georgia Tech, the I3L provides controlled access to applications hosted by other universities and private industry, as well as publicly available applications hosted by state and federal agencies.

The I3L will accelerate innovation by providing a suite of open source and commercial resources, significantly reducing cycle time and cost from idea to market of disruptive HIT. The I3L will provide conformance standards testing, interoperability evaluation, commercialization assistance and more. A critical priority is to create and sustain an evolving, “state-of-the market” educational products suite with which to train the emerging HIT workforce.